Atara Biotherapeutics downgraded by Mizuho with a new price target

11/9/23 6:45:52 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Mizuho downgraded Atara Biotherapeutics from Buy to Neutral and set a new price target of $1.00 from $31.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ATRA

Date	Price Target	Rating	Analyst
11/9/2023		Outperform → In-line	Evercore ISI
11/9/2023		Buy → Neutral	H.C. Wainwright
11/9/2023	$31.00 → $1.00	Buy → Neutral	Mizuho
7/20/2022	$8.00 → $3.00	Neutral → Sell	Citigroup
7/13/2022	$10.00	Overweight → Neutral	JP Morgan
7/13/2022	$16.00 → $5.00	Buy → Hold	Stifel
5/10/2022	$15.00 → $8.00	Buy → Neutral	Citigroup
1/3/2022	$26.00 → $27.00	Overweight	JP Morgan